Thomas Hutson, DO, PharmD, discusses challenges with targeted therapy in non-clear cell renal cell carcinoma.
Thomas E. Hutson, DO, PharmD
Advertisement
Articles by Thomas E. Hutson, DO, PharmD
Advertisement
Latest Updated Articles
Dr. Hutson on Challenges With Targeted Therapy in Non-Clear Cell RCCPublished: January 8th 2021 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
What the Field of Cell and Gene Therapy Needs Most in the Current Moment
2
Steven W. Pipe, MD, on the Implications of the Final Data From Hemgenix’s HOPE-B Trial
3
End-of-Study Results From Hemgenix’s HOPE-B Trial
4
Rabi Hanna, MD, on Practical Considerations for Integrating Gene Therapy
5